<scp>EFNS</scp>/<scp>MDS</scp>‐<scp>ES</scp> recommendations for the diagnosis of <scp>P</scp>arkinson's disease
Alfredo Berardelli(Istituti di Ricovero e Cura a Carattere Scientifico), M Vidailhet(Centre National de la Recherche Scientifique), Joaquim J. Ferreira(University of Lisbon), P. Kanovsky(Palacký University Olomouc), David J. Brooks(Hammersmith Hospital), Angelo Antonini(University of Padua), Vincenzo Bonifati(Erasmus MC), Wolfgang H. Oertel(Philipps University of Marburg), Gregor K. Wenning(Innsbruck Medical University), Carlo Colosimo(Santa Maria Nuova Hospital), Thomas Gasser(Hertie Institute for Clinical Brain Research), Evžen Růžička(Charles University), Anette Schrag(The Royal Free Hospital), Jaime Kulisevsky(Universitat Autònoma de Barcelona), Jens-P. Reese(Institut für Medizinische Informatik, Biometrie und Epidemiologie), V.S. Kostić(University of Belgrade), Pille Taba(Tartu University Hospital), Maja Relja(University Hospital Centre Zagreb), Klaus Seppi(Innsbruck Medical University), W. Poewe(Innsbruck Medical University), Alessandra Fanciulli(Innsbruck Medical University), B.R. Bloem(Radboud University Nijmegen), Daniela Berg(Christian-Albrechts-Universität zu Kiel), Francisco Grandas(Hospital General Universitario Gregorio Marañón), David J. Burn(Newcastle Hospitals - Campus for Ageing and Vitality)
Cited by 490
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k